Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Even a Little Secondhand Smoke Is Dangerous

Article Abstract:

Exposure to passive smoking can affect blood vessel and platelet function adversely, according to studies done in non-smoking humans. Animal studies have also shown that exposure to cigarette smoke on a daily basis can cause atherosclerosis. This supports the epidemiological studies showing a link between passive smoking and heart disease.

Author: Glantz, Stanton A., Parmley, William W.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Editorial, Causes of

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Passive smoking and heart disease: mechanisms and risk

Article Abstract:

Passive smoking appears to adversely affect the cardiovascular system and increases the risk of heart disease. Environmental tobacco smoke (ETS) impedes the blood's oxygen-carrying capacity and interferes with the heart's ability to effectively use oxygen. ETS exposure activates blood platelets, which increases the risk of blood clots and damages the lining in the coronary arteries. Damage to the blood vessel lining allows platelets to stick to the tissue which leads to the formation of fatty plaques and atherosclerosis. Cancer-causing elements in ETS may speed the development of fatty plaques in blood vessels. People who are exposed to ETS are 1.2 to 1.7 times more likely to die from heart disease and have a 1.3 times greater risk of nonfatal heart disease compared to non-exposed people. Because nonsmokers are sporadically exposed to ETS, they never fully adapt to the chemicals in tobacco smoke and exhibit more pronounced health effects than smokers.

Author: Glantz, Stanton A., Parmley, William W.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1995
Physiological aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Environmental tobacco smoke: the Brown and Williamson documents

Article Abstract:

Two major tobacco companies publicly challenged research findings that show environmental smoke can cause cancer in nonsmokers, although their own internal research supported the findings. Confidential documents from Brown and Williamson Tobacco Corp.(B&W) and the British American Tobacco Co.(BAT) obtained from an anonymous source and a former BAT executive were studied. After a landmark paper was published showing that people exposed to environmental smoke increased their risk of developing lung cancer, B&W and BAT sought out research that would oppose that finding. Publicly the tobacco industry said the the conclusion was not proven although BAT researchers had found toxic agents in cigarette smoke years earlier. The company had even tried to develop a cigarette that would emit low sidestream smoke.

Author: Slade, John, Bero, Lisa A., Glantz, Stanton A., Barnes, Deborah E., Hanauer, Peter
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1995
Research, British-American Tobacco Company Ltd., Environmental health, Brown & Williamson Tobacco Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Heart diseases, Passive smoking, Risk factors
Similar abstracts:
  • Abstracts: Seating nonmetal crowns or fixed partial dentures with resin cement. Building up tooth preparations for full crowns -- 2000
  • Abstracts: Economic expansion: how to get the most nutritional bang for your buck. Behind closed doors: the bodybuilder's kitchen
  • Abstracts: Prospective study of alcohol consumption and risk of dementia in older adults. Prior Alcohol Consumption and Mortality Following Acute Myocardial Infarction
  • Abstracts: Transmissible spongiform encephalopathies, amyloidoses and yeast prions: common threads? A novel erythroid-specific marker of transmissible spongiform encephalopathies
  • Abstracts: Improvement in cardiac funtion in the cardiac variant of Fabry's disease with galactose-infusion therapy. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.